QuickView for Fas receptor, death domain (biogroup)

1. Livers and inguinal adipose of diabetic Lepr[db/db] mice treated with rosiglitazone or S compound
2. L1000 CMAP - Breast adenocarcinoma SKBR3 cells treated with small molecule perturbagens
3. L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (1 of 4)
4. Cancer Gene Census - mutations in cancer genes
5. Drug target sets for approved compounds

There were no matches for Fas receptor, death domain

1. An Open Label Study of Postmenopausal Women With Oestrogen Receptor Positive Locally Advanced or Met…
2. Decoy Receptor 3 (DcR3) Polymorphisms in Rheumatoid Arthritis (RA) and Systemic Lupus Erythematosus …
3. A Study Evaluating the Combination of Encorafenib and Cetuximab Versus Irinotecan/Cetuximab or Infus…
4. Herceptin (Trastuzumab) in Treating Women With Human Epidermal Growth Factor Receptor (HER) 2-Positi…
5. Characterization of NK Cells Under First Line Advanced Therapy Either as Curative Therapy for Metast…